Tumor-infiltrating lymphocytes and POLE mutation in endometrial carcinoma
Antonio Raffone(University of Campania "Luigi Vanvitelli"), Renato Seracchioli(Azienda USL di Bologna), Giulia Borghese(University of Bologna), Paolo Casadio(Azienda USL di Bologna), Fulvio Zullo(Magna Graecia University), Antonio Travaglino(University of Insubria), Maria Pia Boccellino(University of Naples Federico II), Manuela Maletta(University of Bologna), Antonio Mollo(Northwestern University), Diego Raimondo(Azienda USL di Bologna), Luigi Insabato(Federico II University Hospital)
Cited by 38
Related Papers
Early Impairment of Endothelial Structure and Function in Young Normal-Weight Women with Polycystic Ovary Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2004|328
Prospective Parallel Randomized, Double-Blind, Double-Dummy Controlled Clinical Trial Comparing Clomiphene Citrate and Metformin as the First-Line Treatment for Ovulation Induction in Nonobese Anovulatory Women with Polycystic Ovary Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2005|281
The Cardiovascular Risk of Young Women with Polycystic Ovary Syndrome: An Observational, Analytical, Prospective Case-Control Study
|The Journal of Clinical Endocrinology & Metabolism|2004|276
The management of Asherman syndrome: a review of literature
|Reproductive Biology and Endocrinology|2013|263
The Increase of Leukocytes as a New Putative Marker of Low-Grade Chronic Inflammation and Early Cardiovascular Risk in Polycystic Ovary Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2005|254